Uterine hyperstimulation without fetal heart rate changes · women in the third trimester for induction of labour.
Oral misoprostol probably leads to lower uterine hyperstimulation without fetal heart rate changes compared with vaginal dinoprostone (moderate certainty).
1 finding from 1 review
Uterine hyperstimulation with fetal heart rate changes · women in the third trimester for induction of labour.
Oral misoprostol may leads to lower uterine hyperstimulation with fetal heart rate changes compared with vaginal misoprostol (low certainty).
1 finding from 1 review
Uterine hyperstimulation without fetal heart rate changes · women in the third trimester for induction of labour.
Oral misoprostol may leads to lower uterine hyperstimulation without fetal heart rate changes compared with vaginal misoprostol (low certainty).
1 finding from 1 review
Uterine hyperstimulation with fetal heart rate changes · women in the third trimester for induction of labour.
It is very uncertain whether oral misoprostol changes uterine hyperstimulation with fetal heart rate changes compared with intravenous oxytocin (very low certainty).
1 finding from 1 review
Uterine hyperstimulation without fetal heart rate changes · women in the third trimester for induction of labour.
It is very uncertain whether oral misoprostol changes uterine hyperstimulation without fetal heart rate changes compared with intravenous oxytocin (very low certainty).
1 finding from 1 review
Uterine hyperstimulation with fetal heart rate changes · women with ruptured membranes in the third trimester for induction of labour.
It is very uncertain whether oral misoprostol changes uterine hyperstimulation with fetal heart rate changes compared with placebo/no treatment (very low certainty).
1 finding from 1 review
Uterine hyperstimulation with fetal heart rate changes · women in the third trimester for induction of labour.
Oral misoprostol showed no clear difference in uterine hyperstimulation with fetal heart rate changes compared with mechanical methods (low certainty).
1 finding from 1 review
Uterine hyperstimulation without fetal heart rate changes · women in the third trimester for induction of labour.
It is very uncertain whether oral misoprostol changes uterine hyperstimulation without fetal heart rate changes compared with mechanical methods (very low certainty).
1 finding from 1 review
Uterine hyperstimulation with fetal heart rate changes · women in the third trimester for induction of labour with intact membranes
1 finding from 1 review
Uterine hyperstimulation without fetal heart rate changes · women in the third trimester for induction of labour with intact membranes
It is very uncertain whether oral misoprostol one‐ to two‐hourly changes uterine hyperstimulation without fetal heart rate changes compared with oral misoprostol four‐ to six‐hourly (very low certainty).
1 finding from 1 review
Uterine hyperstimulation without fetal heart rate changes · women with ruptured membranes in the third trimester for induction of labour.
It is very uncertain whether oral misoprostol changes uterine hyperstimulation without fetal heart rate changes compared with placebo/no treatment (very low certainty).
1 finding from 1 review
Program safety · 9‐ to 47‐month‐old children in LMICs
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Program safety · 9‐ to 47‐month‐old children in LMICs
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Program safety · 1‐ to 5‐year‐old children in LMICs
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Safety of sealants and fluoride varnishes (adverse events) · Children and adolescents (general population, aged under 20 years)
1 finding from 1 review
Fetal distress/asphyxial events · pregnant women with intrahepatic cholestasis
It is very uncertain whether ursodeoxycholic acid (UDCA) changes fetal distress/asphyxial events compared with placebo (very low certainty).
1 finding from 1 review
Withdrawals due to adverse outcomes · women aged 16 and over with uncomplicated vulvovaginal candidiasis
1 finding from 1 review
Intervention not reported
Number of patients with safety events (total AEs, infections, SAEs) · patients with TIA or ischaemic stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Perinatal mortality · women with gestational diabetes mellitus
1 finding from 1 review
Intervention not reported
Safety planning and/or safety behaviour score Service use and activities questionnaire Direction: higher better · women aged 16 years and older who self‐report previous or current experience of intimate partner violence
1 finding from 1 review